First in the 'FDA Basics' Series of Online Sessions for the Public
SILVER SPRING, Md., Feb. 19 /PRNewswire-USNewswire/ -- Do you have questions about the use of investigational drugs for treatment purposes? Here is your opportunity to ask experts from the Food and Drug Administration (FDA) about this important topic, or to just listen in to learn more about investigational drugs.
When: Tuesday, Feb. 23, 2010, at 3 p.m. ET
Richard Klein, HIV/AIDS program director, OSHI
Theresa Toigo, R.Ph., M.B.A., director, OSHI
Also known as experimental drugs, investigational drugs are new drugs that are in the process of being tested for safety and effectiveness. They either have not yet been approved by FDA, or are approved drugs that have not yet been approved for a new use.
Investigational drugs may sometimes be used outside of clinical trials to treat a patient with a serious or immediately life-threatening disease or condition who has no other comparable or satisfactory treatment options. This use is called expanded access, or "compassionate use."
During this webinar, FDA experts will present information on
The presentation will run 30 minutes and will include an opportunity to ask questions.
To join the webinar:
NOTE: If your phone number includes an extension, or if you will attend the teleconference only (not the online visual portion), please use the manual dial-in number: 1-866-628-8620 and passcode: 340910
To verify your ability to access the webinar (recommended for first-time Connect users):
This webinar is the first in a series of monthly online sessions hosted by different FDA centers and offices. The webinar series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.
Sign up for e-mail notices of new FDA Consumer Updates at: https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
View the FDA Consumer Update RSS feed at: http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/Consumers/rss.xml
FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: email@example.com.
SOURCE U.S. Food and Drug AdministrationBack to top
|SOURCE U.S. Food and Drug Administration|
Copyright©2010 PR Newswire.
All rights reserved